Cathie Wood Bristol Myers Squibb CO Transaction History

Ark Investment Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $113 Million - $132 Million	-1,902,838 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$61.91 - $67.42 $17.2 Million - $18.7 Million	-277,081 Reduced 12.71%	1,902,838 $127 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $129 Million - $145 Million	2,179,919 New	2,179,919 $138 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $2.46 Million - $3.58 Million	-53,054 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$49.21 - $64.19 $13.2 Million - $17.2 Million	-267,658 Reduced 83.46%	53,054 $3.41 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $1.36 Million - $1.61 Million	-31,709 Reduced 9.0%	320,712 $16.3 Million
Q2 2019 Jul 30, 2019	BUY	$44.62 - $49.34 $7.05 Million - $7.8 Million	158,104 Added 81.36%	352,421 $16 Million
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $8.77 Million - $10.5 Million	194,317 New	194,317 $9.27 Million
Q4 2018 Feb 01, 2019	SELL	$48.76 - $63.23 $2.7 Million - $3.5 Million	-55,283 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$55.19 - $62.25 $945,735 - $1.07 Million	17,136 Added 44.92%	55,283 $3.43 Million
Q2 2018 Aug 07, 2018	BUY	$50.53 - $62.98 $1.93 Million - $2.4 Million	38,147 New	38,147 $2.11 Million

2,536

1.46B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.